Industry practices remain unstandardized, with product quality and service equally important.
The pharmaceutical market is currently in a period of intense competition, with numerous players vying for dominance. The sector features a large number of fragmented enterprises, and market competition and industry regulations remain unstandardized. High-quality competitors are constrained by disorderly competition, leading to a situation where inferior products drive out superior ones. However, industry trends…
